Meta AnalysisID 6696

中药注射液联合化疗治疗中晚期乳腺癌的网状Meta分析

CRD42023485927

What is the efficacy of combining Traditional Chinese Medicine (TCM) injections with chemotherapy in treating middle-advanced breast cancer patients, as compared to chemotherapy alone?

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Formula: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
6696
Evidence Id
15254
Core Evidence Id
15254
Source Meta Analysis Id
6677
Herb2 Meta Analysis Id
HBMA006677
Crd Id
CRD42023485927
Title
A network meta-analysis of traditional Chinese medicine injections combined with chemotherapy to middle-advanced breast cancer
Review Question
What is the efficacy of combining Traditional Chinese Medicine (TCM) injections with chemotherapy in treating middle-advanced breast cancer patients, as compared to chemotherapy alone?
Study Type Included
We will include randomized trials to assess the beneficial effects of the treatments.
Condition Being Studied
Breast cancer is the most frequently occurring tumor in women.
Participant
Inclusion: Women with advanced breast cancer Exclusion: Women with early breast cancer
Animal
Human Disease Modelled
Intervention
Different TCM injections(Shenqi Fuzheng Injection, Huachansu Injection, compound Kushen Injection, Shengfu Injection, Kangai injection, Huangqi Injection, Shenmai Injection, Brucea javanica oil emulsion injection, Aidi Injection, Lanxiangxi Injection)+chemotherapy
Comparator Control
chemotherapy only
Main Outcome
Our main outcomes will be measured using ORR (Objective Response Rate) and DCR (Disease Control Rate).
Outcome Measure
Additional Outcome
We will use CD4/CD8 ratio and AEs(Adverse Events) as additional outcomes.
Study Method
Network meta-analysis, Systematic review
Keyword
MeSH headings have not been applied to this record
Contact
Gao Xiufei [email protected]
Organisational Affiliation
Zhejiang Chinese Medical University(ZCMU)
Funding Source
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
China
Review Stage
Review Ongoing
First Submission Date
2023-11-23
Registration Date
2023-12-05
Anticipated Start Date
2023-11-01
Anticipated Completion Date
2024-05-31
Title Cn
中药注射液联合化疗治疗中晚期乳腺癌的网状Meta分析
Title En
A network meta-analysis of traditional Chinese medicine injections combined with chemotherapy to middle-advanced breast cancer
Bilingual Status
complete